TrialJournal of neuro-oncology2021

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.

Nitesh V Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.